Correlation Analysis
Alnylam Pharmaceuticals, Inc. vs Micron Technology, Inc.
ALNY vs MU
+0.594
Moderate positive
When one moves up, the other tends to follow.
Alnylam Pharmaceuticals, Inc.
↗ALNY
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi therapeutic products include Onpattro and Amvuttra (for hATTR amyloidosis), Givlaari (for acute hepatic porphyria), and Oxlumo (for primary hyperoxaluria type 1), all developed and commercialized by Alnylam. Plus, Leqvio (for hypercholesterolemia) and Qfitlia (for hemophilia A or B), which are being commercialized by Alnylam's partners, Novartis and Sanofi, respectively. It also has several clinical programs across various therapeutic areas, including cardio-metabolic diseases, neuroscience, and hematology.
Market cap 43.8B · 2,500 employees
Micron Technology, Inc.
↗MU
Micron is one of the largest semiconductor companies in the world, specializing in memory and storage chips. Its primary revenue stream comes from dynamic random access memory, or DRAM, and it also has minority exposure to not-and or NAND, flash chips. Micron serves a global customer base, selling chips into data centers, mobile phones, consumer electronics, and industrial and automotive applications. The firm is vertically integrated.
Market cap 426B · 53,000 employees
Time Series
Relative Performance
Who Moves First
ALNY leads MU by 6 days
ALNY tends to move before MU.
After testing 13 timing shifts, the strongest relationship was +0.614 (they moved in the same direction).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
+0.581
7 periods · Return correlation when both series rose
Both Falling
+0.278
9 periods · Return correlation when both series fell
Diverging
-0.757
19 periods · Return correlation when series moved apart
R-Squared
35.3%
Share of variance in one series explained by the other.
Trend Agreement
56.8%
How often both series moved in the same direction period-to-period.
Overlap Quality
1,253
Deep shared window — 1,253 usable pairs.
Significance
p < 0.001
95% CI: [0.557, 0.629]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
1,253 paired data points survived the daily window.
Raw input
1,253
1,254
Normalized
1,253
1,254
Prepared
1,253
1,254
Aligned
1,253
1,253
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
1
A: 0 / B: 1
Series A
Alnylam Pharmaceuticals, Inc.
ALNY
Market cap 43.8B · 2,500 employees
Stock · 1,253 raw → 1,253 prepared
Series B
Micron Technology, Inc.
MU
Market cap 426B · 53,000 employees
Stock · 1,254 raw → 1,254 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
18
Estimated crossover points between normalized spreads.
Slope
0.5363
Linear regression slope.
Intercept
-15.6378
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
ALNY
Alnylam Pharmaceuticals, Inc.
Highest
+0.842
JPMorgan Chase & Co.
JPM · 1,253 data points
Lowest
+0.460
Johnson & Johnson
JNJ · 1,253 data points
Saved 6 hours ago · ID: stock-alny-vs-stock-mu-daily